{
    "clinical_study": {
        "@rank": "97584", 
        "arm_group": {
            "arm_group_label": "Breast Mastopexy &/or reduction using GalaFlex Mesh", 
            "arm_group_type": "Other"
        }, 
        "brief_summary": {
            "textblock": "This study is to assess the physician preference in the clinical performance of the GalaFLEX\n      mesh in soft tissue reinforcement during elective (cosmetic) plastic surgery to the breast,\n      in particular the breast lift mastopexy and breast reduction procedures"
        }, 
        "brief_title": "Use of GalaFlex in Ptotic Breast", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Ptotic Breast", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subject is able to understand the risks and benefits of participating in the study\n             and must be willing to sign and date the Informed Consent Form for this study\n             approved by the Institutional Review Board (IRB.)\n\n          2. Be at least 21 years of age.\n\n          3. Be willing and able to comply with the requirements of the protocol.\n\n          4. Be willing to refrain from participating in any other investigational interventional\n             study while enrolled in this study.\n\n          5. Female subjects must have a negative pregnancy test within the last 24 hours timeline\n             and have no intentions of becoming pregnant during participation in the study, or be\n             sterilized.\n\n        Exclusion Criteria:\n\n          1. Subjects unwilling or unable to give written consent to participate in the\n             investigation or unable to comply with the requirements of the protocol.\n\n          2. Subjects with known severe allergies manifested by a history of anaphylaxis or\n             allergy to GalaFLEX mesh, poly-4-hydroxybutyrate (P4HB), a resorbable polymer, or\n             silicone.\n\n          3. Subjects with known active infection and/or who received or are targeted to receive\n             immunosuppressive therapy over the course of the study (such as rheumatoid\n             arthritis).\n\n          4. Subjects who received any experimental drug or device within the previous three\n             months.\n\n          5. Female subjects who were pregnant or lactating or were intending to become pregnant\n             during the period of the study, or who would not use an adequate method of\n             contraception (contraceptive pill, intra-uterine device) for the duration of the\n             study.\n\n          6. Possessed any psychological condition, or was under treatment for any condition\n             which, in the opinion of the Investigator and/or consulting physicians(s), would\n             constitute an unwarranted risk.\n\n          7. Have collagen-vascular, connective disease, or bleeding disorders.\n\n          8. Have a BMI that is greater than or equal to 30.\n\n          9. Have any disease, including uncontrolled diabetes, which is clinically known to\n             impact wound healing ability.\n\n         10. Have an autoimmune disease, an immune deficiency, or is on immune suppression drugs.\n\n         11. Currently have an alcohol/substance abuse problem or have had a relapse within 1 year\n             prior to screening visit.\n\n         12. Have concomitant unrelated condition of breast/chest wall/skin.\n\n         13. Have undergone previous breast surgery with the exception of breast biopsy.\n\n         14. Subject is currently a smoker or is a prior smoker who quit in the last 12 months.\n\n         15. Currently involved with claims for, or is accepting workers compensation.\n\n         16. Currently engaged in medical malpractice litigation.\n\n             -"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02081157", 
            "org_study_id": "CP-1050"
        }, 
        "intervention": {
            "arm_group_label": "Breast Mastopexy &/or reduction using GalaFlex Mesh", 
            "intervention_name": "GalaFlex Mesh", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 5, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Ponte Verdra Beach", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32083"
                    }, 
                    "name": "Ponte Vedra Plastic Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46290"
                    }, 
                    "name": "Meridian Plastic Surgeons"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brookline", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02445"
                    }, 
                    "name": "Longwood Plastic Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Creve Coeur", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63141"
                    }, 
                    "name": "Parkcrest Plastic Surgical"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sea Girt", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08750"
                    }, 
                    "name": "Glicksman Plastic Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York City", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "New York-Presbyterian Hospital, the University Hospital of Columbia and Cornell"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75205"
                    }, 
                    "name": "William P. Adams, M.D."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mountlake Terrace", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98043"
                    }, 
                    "name": "Plastic Surgery Clinic"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Use of GalaFlex in Ptotic Breast", 
        "other_outcome": {
            "measure": "\u2022 Long term visibility:  Mammography and ultrasound will be used to evaluate the presence of the mesh or potential for mesh interference in evaluation of the breast tissue.", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "overall_official": {
            "affiliation": "Tepha, Inc", 
            "last_name": "Arikha Moses, Ph.D", 
            "role": "Study Director"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Investigator satisfaction with the surgical implantation/usage of GalaFLEX mesh in elective plastic surgery to the breast evaluated using a surgeon satisfaction questionnaire.", 
            "safety_issue": "No", 
            "time_frame": "1year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02081157"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Technical Performance of the GalaFLEX mesh:  evaluation of the resolution of ptosis will be evaluated based on the change in nipple to IMF distance and sternal notch to nipple distance pre- and post-surgery.", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "source": "Galatea, Corp", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Galatea, Corp", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}